SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-028261
Filing Date
2024-02-27
Accepted
2024-02-27 16:53:40
Documents
2
Group Members
PHILLIP FROST, M.D.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm247389d1_sc13da.htm SC 13D/A 59858
2 EXHIBIT 1 tm247389d1_ex1.htm EX-99.1 4493
  Complete submission text file 0001104659-24-028261.txt   66235
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Subject) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52381 | Film No.: 24687940
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4400 BISCAYNE BLVD MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD MIAMI FL 33137 305-575-6511
Frost Gamma Investments Trust (Filed by) CIK: 0001380896 (see all company filings)

IRS No.: 460464745
Type: SC 13D/A